# First-in-Human Study to Investigate the Safety and Tolerability and Pharmacokinetics of HS-10383

> **NCT05429723** · PHASE1 · UNKNOWN · sponsor: **Jiangsu Hansoh Pharmaceutical Co., Ltd.** · enrollment: 32 (estimated)

## Conditions studied

- Cough

## Interventions

- **DRUG:** HS-10383
- **DRUG:** HS-10383 Placebo

## Key facts

- **NCT ID:** NCT05429723
- **Lead sponsor:** Jiangsu Hansoh Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-01
- **Primary completion:** 2022-06-30
- **Final completion:** 2022-06-30
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2022-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05429723

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05429723, "First-in-Human Study to Investigate the Safety and Tolerability and Pharmacokinetics of HS-10383". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05429723. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*